Myelodysplastic Syndrome

Showing NaN - NaN of 71

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Myelodysplastic Syndrome Trial in New York (WT1-sensitized T cells)

Completed
  • Leukemia
  • Myelodysplastic Syndrome
  • WT1-sensitized T cells
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 1, 2021

Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727

Completed
  • Myelodysplastic Syndrome
  • MDS
  • ASTX727 Dose Escalation
  • +2 more
  • Phoenix, Arizona
  • +16 more
Dec 1, 2020

Women Who Survived Cancer orRelated Illness Following Total Body

Completed
  • Leukemia
  • +3 more
  • Questionnaires, Laboratory tests, Abdominal MRI
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 3, 2020

Myelodysplastic Syndrome Trial in New York (rigosertib)

Withdrawn
  • Myelodysplastic Syndrome
  • New York, New York
    Columbia University Medical Center
Jun 29, 2020

Testing in Patients Undergoing Hematopoietic Cell

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • Symptom-limited cardiopulmonary exercise test (CPET)
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 15, 2020

Myelodysplastic Syndrome Trial in United States (CC-11006)

Terminated
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +6 more
Dec 11, 2019

Multi-center, Survival Data Collection in Subjects Previously

Completed
  • Myelodysplastic Syndrome
    • Scottsdale, Arizona
    • +14 more
    Nov 6, 2019

    Myelodysplastic Syndrome Trial in New York (lenalidomide, cyclosporine A)

    Terminated
    • Myelodysplastic Syndrome
    • New York, New York
      Weill Cornell Medical College
    Nov 1, 2019

    Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma Trial in New York (Cyclophosphamide)

    Terminated
    • Leukemia
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 22, 2019

    Myelodysplastic Syndrome Trial in Worldwide (MEDI4736 Evaluate MEDI4736 in MDS, VIDAZA, tremelimumab)

    Completed
    • Myelodysplastic Syndrome
    • MEDI4736 Evaluate MEDI4736 in MDS
    • +2 more
    • Scottsdale, Arizona
    • +20 more
    May 9, 2019

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome, Hematologic Malignancies Trial in France, United States (AG881)

    Completed
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Aurora, Colorado
    • +5 more
    Mar 6, 2019

    Myelodysplastic Syndrome Trial in New York (Vosaroxin)

    Completed
    • Myelodysplastic Syndrome
    • New York, New York
      Weill Cornell Medical College
    Jan 24, 2019

    Myelodysplastic Syndrome Trial in United States (vadastuximab talirine, Azacitidine, Placebo (for 33A))

    Terminated
    • Myelodysplastic Syndrome
    • vadastuximab talirine
    • +2 more
    • Gilbert, Arizona
    • +33 more
    Jan 23, 2019

    Myelodysplastic Syndrome Trial in United States (OPN-305)

    Completed
    • Myelodysplastic Syndrome
    • Tampa, Florida
    • +3 more
    Jan 24, 2019

    Solid Tumors, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United States (PLX51107)

    Terminated
    • Solid Tumors
    • +3 more
    • New York, New York
    • +4 more
    Dec 20, 2018

    Myelodysplastic Syndrome Trial in United States (pracinostat, Placebo, Azacitidine)

    Completed
    • Myelodysplastic Syndrome
    • Mobile, Alabama
    • +23 more
    Sep 11, 2018

    Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug, biological, procedure, other)

    Terminated
    • Acute Leukemia
    • +3 more
    • total-body irradiation (TBI)
    • +7 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 12, 2018

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in New York (device, drug, procedure)

    Terminated
    • Acute Myelogenous Leukemia
    • +4 more
    • CliniMACS® CD34 Reagent System
    • +5 more
    • New York, New York
      Weill Cornell Medical College
    Jun 12, 2018

    Aplastic Anemia, Leukemia, Myelodysplastic Syndrome Trial in United States (Busulfan, fludarabine, & cyclophosphamide with

    Completed
    • Aplastic Anemia
    • +2 more
    • Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.
    • CliniMACS device
    • Boston, Massachusetts
    • +5 more
    Jun 14, 2018

    Myelodysplastic Syndrome Trial in New York (Tosedostat)

    Completed
    • Myelodysplastic Syndrome
    • New York, New York
      Weill Cornell Medical College
    Jun 7, 2018

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (micafungin, posaconazole)

    Completed
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Apr 4, 2018

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome

    Completed
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +5 more
    • Ipilimumab
    • Laboratory Biomarker Analysis
    • New Haven, Connecticut
    • +8 more
    Mar 20, 2018

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (CPX-351)

    Completed
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • New York, New York
      Weill Cornell Medical College
    Jan 12, 2018